Open access · CC-BY
via OpenAlex
Immunosenescence in aging and neurodegenerative diseases: evidence, key hallmarks, and therapeutic implications
Zhichun Chen, Zixu Mao, Weiting Tang, Yuxuan Shi, Jun Liu, Yong You
Translational Neurodegeneration · 2025 · ▲ 27 citations
Genomic instability
Telomere attrition
Epigenetic alterations
Loss of proteostasis
Dysbiosis
Mitochondrial dysfunction
Cellular senescence
Stem-cell exhaustion
Altered intercellular communication
Chronic inflammation
Review
Abstract
Aging is a multifaceted biological process affecting various organ systems. Immunosenescence, a key feature of aging, markedly increases susceptibility to infections, cancers, autoimmune diseases, and also neurodegenerative disorders. Immunosenescence not only accelerates normal aging but also drives the progression of neurodegenerative diseases, including Alzheimer's disease (AD) and Parkinson's disease (PD). However, the lack of a consensus on the mechanistic hallmarks of immunosenescence presents a major barrier to the development and validation of anti-aging therapies. In this review, we propose 11 hallmarks of immunosenescence: genomic instability, telomere(definition) attrition, epigenetic dysregulation, stem cell exhaustion, loss of proteostasis(definition), deregulated nutrient-sensing, mitochondrial dysfunction(definition), cellular senescence(definition), chronic inflammation, altered intercellular communication, and microbiome dysbiosis. We also elucidate the intricate interplay between immunosenescence and both normal brain aging and neurodegenerative pathologies, highlighting the pivotal involvement of age-related immune dysregulation in the pathogenesis of neurodegenerative disorders. This mechanistic connection is particularly evident in prototypical neurodegenerative conditions such as AD and PD, where immunosenescence appears to significantly contribute to disease progression and phenotypic manifestations. Given that the ultimate goal of immune aging research is to prevent or alleviate age-related diseases, we also discuss potential hallmark-targeting anti-immunosenescence strategies to delay or even reverse normal aging and neurodegeneration.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1186/s40035-025-00517-1
- Canonical
- link ↗
- Fetched
- 2026-11-13 MST
Cite this
APA
Chen, Z., Mao, Z., Tang, W., Shi, Y., Liu, J., & You, Y. (2025). Immunosenescence in aging and neurodegenerative diseases: evidence, key hallmarks, and therapeutic implications. <em>Translational Neurodegeneration</em>. https://doi.org/10.1186/s40035-025-00517-1
Vancouver
Chen Z, Mao Z, Tang W, Shi Y, Liu J, You Y. Immunosenescence in aging and neurodegenerative diseases: evidence, key hallmarks, and therapeutic implications. Translational Neurodegeneration. 2025. doi:10.1186/s40035-025-00517-1.
BibTeX
@article{zhichun2025Immuno,
title = {Immunosenescence in aging and neurodegenerative diseases: evidence, key hallmarks, and therapeutic implications},
author = {Zhichun Chen and Zixu Mao and Weiting Tang and Yuxuan Shi and Jun Liu and Yong You},
journal = {Translational Neurodegeneration},
year = {2025},
doi = {10.1186/s40035-025-00517-1},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Translational neurodegeneration 2025
Open access · OA
Immunosenescence in aging and neurodegenerative diseases: evidence, key hallmarks, and therapeutic implications.
Zenodo (CERN European Organization for Nuclear Research) 2026
Preprint · CC-BY
A Review Article on Aging and Age-Related Disorders
Springer eBooks 2023
Citation only
Age-Related Neurodegenerative Diseases: Aging and Neurodegeneration
Neural Regeneration Research 2025
Open access · CC-BY
Targeting innovative therapeutic approaches to the hallmarks of aging to combat Alzheimer’s disease
Neural regeneration research 2026
Open access · OA
Targeting innovative therapeutic approaches to the hallmarks of aging to combat Alzheimer's disease.
Aging Cell 2024
Open access · CC-BY